140 related articles for article (PubMed ID: 37863341)
1. Hotspot mutations and genomic expansion of ERG11 are major mechanisms of azole resistance in environmental and human commensal isolates of Candida tropicalis.
Hu T; Wang S; Bing J; Zheng Q; Du H; Li C; Guan Z; Bai FY; Nobile CJ; Chu H; Huang G
Int J Antimicrob Agents; 2023 Dec; 62(6):107010. PubMed ID: 37863341
[TBL] [Abstract][Full Text] [Related]
2. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China.
Fan X; Xiao M; Zhang D; Huang JJ; Wang H; Hou X; Zhang L; Kong F; Chen SC; Tong ZH; Xu YC
Clin Microbiol Infect; 2019 Jul; 25(7):885-891. PubMed ID: 30472420
[TBL] [Abstract][Full Text] [Related]
4. MDR1 overexpression combined with ERG11 mutations induce high-level fluconazole resistance in Candida tropicalis clinical isolates.
Jin L; Cao Z; Wang Q; Wang Y; Wang X; Chen H; Wang H
BMC Infect Dis; 2018 Apr; 18(1):162. PubMed ID: 29631565
[TBL] [Abstract][Full Text] [Related]
5. Analysis of CDR1 and MDR1 Gene Expression and ERG11 Substitutions in Clinical Candida tropicalis Isolates from Alexandria, Egypt.
El-Kholy MA; Helaly GF; El Ghazzawi EF; El-Sawaf G; Shawky SM
Braz J Microbiol; 2023 Dec; 54(4):2609-2615. PubMed ID: 37606863
[TBL] [Abstract][Full Text] [Related]
6. Candida tropicalis distribution and drug resistance is correlated with ERG11 and UPC2 expression.
Wang D; An N; Yang Y; Yang X; Fan Y; Feng J
Antimicrob Resist Infect Control; 2021 Mar; 10(1):54. PubMed ID: 33722286
[TBL] [Abstract][Full Text] [Related]
7. Genetic relatedness among azole-resistant Candida tropicalis clinical strains in Taiwan from 2014 to 2018.
Zhou ZL; Tseng KY; Chen YZ; Tsai DJ; Wu CJ; Chen YC; Peng HL; Yang YL; Hsieh LY; Chen CH; Hsu CH; Wang LS; Cheng MF; Hsu GJ; Kao CC; Hu BS; Lee YT; Liu JW; Liu KS; Miu WC; Yang HM; Yeh YC; Lo HJ
Int J Antimicrob Agents; 2022 Jun; 59(6):106592. PubMed ID: 35460852
[TBL] [Abstract][Full Text] [Related]
8.
Navarro-Rodríguez P; López-Fernández L; Martin-Vicente A; Guarro J; Capilla J
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33077654
[TBL] [Abstract][Full Text] [Related]
9. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
Carvajal SK; Melendres J; Escandón P; Firacative C
Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of ERG11 polymorphism associated azole resistance in Candida tropicalis.
Paul S; Dadwal R; Singh S; Shaw D; Chakrabarti A; Rudramurthy SM; Ghosh AK
PLoS One; 2021; 16(1):e0245160. PubMed ID: 33439909
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.
Eddouzi J; Parker JE; Vale-Silva LA; Coste A; Ischer F; Kelly S; Manai M; Sanglard D
Antimicrob Agents Chemother; 2013 Jul; 57(7):3182-93. PubMed ID: 23629718
[TBL] [Abstract][Full Text] [Related]
12. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China.
Jiang C; Dong D; Yu B; Cai G; Wang X; Ji Y; Peng Y
J Antimicrob Chemother; 2013 Apr; 68(4):778-85. PubMed ID: 23221625
[TBL] [Abstract][Full Text] [Related]
14.
Nishimoto AT; Wiederhold NP; Flowers SA; Zhang Q; Kelly SL; Morschhäuser J; Yates CM; Hoekstra WJ; Schotzinger RJ; Garvey EP; Rogers PD
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30910896
[TBL] [Abstract][Full Text] [Related]
15. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
16. Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
Choi MJ; Won EJ; Shin JH; Kim SH; Lee WG; Kim MN; Lee K; Shin MG; Suh SP; Ryang DW; Im YJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3653-61. PubMed ID: 27044550
[TBL] [Abstract][Full Text] [Related]
17. Pan-azole-resistant Candida tropicalis carrying homozygous erg11 mutations at position K143R: a new emerging superbug?
Xisto MI; Caramalho RD; Rocha DA; Ferreira-Pereira A; Sartori B; Barreto-Bergter E; Junqueira ML; Lass-Flörl C; Lackner M
J Antimicrob Chemother; 2017 Apr; 72(4):988-992. PubMed ID: 28065893
[TBL] [Abstract][Full Text] [Related]
18. Emergence and circulation of azole-resistant
Ceballos-Garzon A; Peñuela A; Valderrama-Beltrán S; Vargas-Casanova Y; Ariza B; Parra-Giraldo CM
Front Cell Infect Microbiol; 2023; 13():1136217. PubMed ID: 37026059
[TBL] [Abstract][Full Text] [Related]
19. Virulence Factors and Azole-Resistant Mechanism of Candida Tropicalis Isolated from Candidemia.
Sasani E; Yadegari MH; Khodavaisy S; Rezaie S; Salehi M; Getso MI
Mycopathologia; 2021 Dec; 186(6):847-856. PubMed ID: 34410566
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
